1 Study Coverage
1.1 Brucella Abortus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Brucella Abortus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 DNA Vaccines
1.2.3 Subunit Vaccines
1.2.4 Vector Vaccines
1.2.5 B. Abortus Recombinant Mutants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Brucella Abortus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cattles
1.3.3 Sheep
1.3.4 Pigs
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Brucella Abortus Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Brucella Abortus Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Brucella Abortus Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Brucella Abortus Vaccine Sales by Region
2.4.1 Global Brucella Abortus Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Brucella Abortus Vaccine by Region (2023-2028)
2.5 Global Brucella Abortus Vaccine Revenue by Region
2.5.1 Global Brucella Abortus Vaccine Revenue by Region (2017-2022)
2.5.2 Global Brucella Abortus Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Brucella Abortus Vaccine Sales by Manufacturers
3.1.1 Global Top Brucella Abortus Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Brucella Abortus Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Brucella Abortus Vaccine in 2021
3.2 Global Brucella Abortus Vaccine Revenue by Manufacturers
3.2.1 Global Brucella Abortus Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Brucella Abortus Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Brucella Abortus Vaccine Revenue in 2021
3.3 Global Brucella Abortus Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Brucella Abortus Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Brucella Abortus Vaccine Sales by Type
4.1.1 Global Brucella Abortus Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Brucella Abortus Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Brucella Abortus Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Brucella Abortus Vaccine Revenue by Type
4.2.1 Global Brucella Abortus Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Brucella Abortus Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Brucella Abortus Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Brucella Abortus Vaccine Price by Type
4.3.1 Global Brucella Abortus Vaccine Price by Type (2017-2022)
4.3.2 Global Brucella Abortus Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Brucella Abortus Vaccine Sales by Application
5.1.1 Global Brucella Abortus Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Brucella Abortus Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Brucella Abortus Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Brucella Abortus Vaccine Revenue by Application
5.2.1 Global Brucella Abortus Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Brucella Abortus Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Brucella Abortus Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Brucella Abortus Vaccine Price by Application
5.3.1 Global Brucella Abortus Vaccine Price by Application (2017-2022)
5.3.2 Global Brucella Abortus Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Brucella Abortus Vaccine Market Size by Type
6.1.1 North America Brucella Abortus Vaccine Sales by Type (2017-2028)
6.1.2 North America Brucella Abortus Vaccine Revenue by Type (2017-2028)
6.2 North America Brucella Abortus Vaccine Market Size by Application
6.2.1 North America Brucella Abortus Vaccine Sales by Application (2017-2028)
6.2.2 North America Brucella Abortus Vaccine Revenue by Application (2017-2028)
6.3 North America Brucella Abortus Vaccine Market Size by Country
6.3.1 North America Brucella Abortus Vaccine Sales by Country (2017-2028)
6.3.2 North America Brucella Abortus Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Brucella Abortus Vaccine Market Size by Type
7.1.1 Europe Brucella Abortus Vaccine Sales by Type (2017-2028)
7.1.2 Europe Brucella Abortus Vaccine Revenue by Type (2017-2028)
7.2 Europe Brucella Abortus Vaccine Market Size by Application
7.2.1 Europe Brucella Abortus Vaccine Sales by Application (2017-2028)
7.2.2 Europe Brucella Abortus Vaccine Revenue by Application (2017-2028)
7.3 Europe Brucella Abortus Vaccine Market Size by Country
7.3.1 Europe Brucella Abortus Vaccine Sales by Country (2017-2028)
7.3.2 Europe Brucella Abortus Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Brucella Abortus Vaccine Market Size by Type
8.1.1 Asia Pacific Brucella Abortus Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Brucella Abortus Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Brucella Abortus Vaccine Market Size by Application
8.2.1 Asia Pacific Brucella Abortus Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Brucella Abortus Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Brucella Abortus Vaccine Market Size by Region
8.3.1 Asia Pacific Brucella Abortus Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Brucella Abortus Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Brucella Abortus Vaccine Market Size by Type
9.1.1 Latin America Brucella Abortus Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Brucella Abortus Vaccine Revenue by Type (2017-2028)
9.2 Latin America Brucella Abortus Vaccine Market Size by Application
9.2.1 Latin America Brucella Abortus Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Brucella Abortus Vaccine Revenue by Application (2017-2028)
9.3 Latin America Brucella Abortus Vaccine Market Size by Country
9.3.1 Latin America Brucella Abortus Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Brucella Abortus Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Brucella Abortus Vaccine Market Size by Type
10.1.1 Middle East and Africa Brucella Abortus Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Brucella Abortus Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Brucella Abortus Vaccine Market Size by Application
10.2.1 Middle East and Africa Brucella Abortus Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Brucella Abortus Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Brucella Abortus Vaccine Market Size by Country
10.3.1 Middle East and Africa Brucella Abortus Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Zoetis Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zoetis Recent Developments
11.2 CEVA
11.2.1 CEVA Corporation Information
11.2.2 CEVA Overview
11.2.3 CEVA Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CEVA Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CEVA Recent Developments
11.3 Merck Animal Health
11.3.1 Merck Animal Health Corporation Information
11.3.2 Merck Animal Health Overview
11.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Animal Health Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Animal Health Recent Developments
11.4 Biovet
11.4.1 Biovet Corporation Information
11.4.2 Biovet Overview
11.4.3 Biovet Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biovet Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biovet Recent Developments
11.5 CAVAC
11.5.1 CAVAC Corporation Information
11.5.2 CAVAC Overview
11.5.3 CAVAC Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CAVAC Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CAVAC Recent Developments
11.6 JOVAC
11.6.1 JOVAC Corporation Information
11.6.2 JOVAC Overview
11.6.3 JOVAC Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 JOVAC Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 JOVAC Recent Developments
11.7 Merial
11.7.1 Merial Corporation Information
11.7.2 Merial Overview
11.7.3 Merial Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merial Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merial Recent Developments
11.8 Colorado Serum Company
11.8.1 Colorado Serum Company Corporation Information
11.8.2 Colorado Serum Company Overview
11.8.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Colorado Serum Company Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Colorado Serum Company Recent Developments
11.9 VECOL
11.9.1 VECOL Corporation Information
11.9.2 VECOL Overview
11.9.3 VECOL Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 VECOL Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 VECOL Recent Developments
11.10 Tecnovax
11.10.1 Tecnovax Corporation Information
11.10.2 Tecnovax Overview
11.10.3 Tecnovax Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Tecnovax Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tecnovax Recent Developments
11.11 Indian Immunologicals
11.11.1 Indian Immunologicals Corporation Information
11.11.2 Indian Immunologicals Overview
11.11.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Indian Immunologicals Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Indian Immunologicals Recent Developments
11.12 Vetal
11.12.1 Vetal Corporation Information
11.12.2 Vetal Overview
11.12.3 Vetal Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Vetal Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Vetal Recent Developments
11.13 Dollvet
11.13.1 Dollvet Corporation Information
11.13.2 Dollvet Overview
11.13.3 Dollvet Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Dollvet Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Dollvet Recent Developments
11.14 Centro Diagnostico Veterinario
11.14.1 Centro Diagnostico Veterinario Corporation Information
11.14.2 Centro Diagnostico Veterinario Overview
11.14.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Centro Diagnostico Veterinario Recent Developments
11.15 Onderstepoort Biological Products
11.15.1 Onderstepoort Biological Products Corporation Information
11.15.2 Onderstepoort Biological Products Overview
11.15.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Onderstepoort Biological Products Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Onderstepoort Biological Products Recent Developments
11.16 Institute of Animal Health and Veterinary Biologicals
11.16.1 Institute of Animal Health and Veterinary Biologicals Corporation Information
11.16.2 Institute of Animal Health and Veterinary Biologicals Overview
11.16.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
11.17 Biogenesis Bago
11.17.1 Biogenesis Bago Corporation Information
11.17.2 Biogenesis Bago Overview
11.17.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Biogenesis Bago Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Biogenesis Bago Recent Developments
11.18 Instituto Rosenbusch
11.18.1 Instituto Rosenbusch Corporation Information
11.18.2 Instituto Rosenbusch Overview
11.18.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Instituto Rosenbusch Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Instituto Rosenbusch Recent Developments
11.19 SYVA Laboratorios
11.19.1 SYVA Laboratorios Corporation Information
11.19.2 SYVA Laboratorios Overview
11.19.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 SYVA Laboratorios Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 SYVA Laboratorios Recent Developments
11.20 CZ Veterinaria
11.20.1 CZ Veterinaria Corporation Information
11.20.2 CZ Veterinaria Overview
11.20.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 CZ Veterinaria Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 CZ Veterinaria Recent Developments
11.21 Hester Biosciences
11.21.1 Hester Biosciences Corporation Information
11.21.2 Hester Biosciences Overview
11.21.3 Hester Biosciences Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Hester Biosciences Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Hester Biosciences Recent Developments
11.22 Qilu Animal Health
11.22.1 Qilu Animal Health Corporation Information
11.22.2 Qilu Animal Health Overview
11.22.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Qilu Animal Health Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Qilu Animal Health Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Brucella Abortus Vaccine Industry Chain Analysis
12.2 Brucella Abortus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Brucella Abortus Vaccine Production Mode & Process
12.4 Brucella Abortus Vaccine Sales and Marketing
12.4.1 Brucella Abortus Vaccine Sales Channels
12.4.2 Brucella Abortus Vaccine Distributors
12.5 Brucella Abortus Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Brucella Abortus Vaccine Industry Trends
13.2 Brucella Abortus Vaccine Market Drivers
13.3 Brucella Abortus Vaccine Market Challenges
13.4 Brucella Abortus Vaccine Market Restraints
14 Key Findings in The Global Brucella Abortus Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Brucella Abortus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of DNA Vaccines
Table 3. Major Manufacturers of Subunit Vaccines
Table 4. Major Manufacturers of Vector Vaccines
Table 5. Major Manufacturers of B. Abortus Recombinant Mutants
Table 6. Major Manufacturers of Others
Table 7. Global Brucella Abortus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Brucella Abortus Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Brucella Abortus Vaccine Sales by Region (2017-2022) & (K Units)
Table 10. Global Brucella Abortus Vaccine Sales Market Share by Region (2017-2022)
Table 11. Global Brucella Abortus Vaccine Sales by Region (2023-2028) & (K Units)
Table 12. Global Brucella Abortus Vaccine Sales Market Share by Region (2023-2028)
Table 13. Global Brucella Abortus Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Brucella Abortus Vaccine Revenue Market Share by Region (2017-2022)
Table 15. Global Brucella Abortus Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Brucella Abortus Vaccine Revenue Market Share by Region (2023-2028)
Table 17. Global Brucella Abortus Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Brucella Abortus Vaccine Sales Share by Manufacturers (2017-2022)
Table 19. Global Brucella Abortus Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Brucella Abortus Vaccine Revenue Share by Manufacturers (2017-2022)
Table 21. Brucella Abortus Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
Table 22. Global Brucella Abortus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Brucella Abortus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucella Abortus Vaccine as of 2021)
Table 24. Brucella Abortus Vaccine Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Brucella Abortus Vaccine Product Offered
Table 26. Date of Manufacturers Enter into Brucella Abortus Vaccine Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 29. Global Brucella Abortus Vaccine Sales by Type (2023-2028) & (K Units)
Table 30. Global Brucella Abortus Vaccine Sales Share by Type (2017-2022)
Table 31. Global Brucella Abortus Vaccine Sales Share by Type (2023-2028)
Table 32. Global Brucella Abortus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Brucella Abortus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Brucella Abortus Vaccine Revenue Share by Type (2017-2022)
Table 35. Global Brucella Abortus Vaccine Revenue Share by Type (2023-2028)
Table 36. Brucella Abortus Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 37. Global Brucella Abortus Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
Table 38. Global Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 39. Global Brucella Abortus Vaccine Sales by Application (2023-2028) & (K Units)
Table 40. Global Brucella Abortus Vaccine Sales Share by Application (2017-2022)
Table 41. Global Brucella Abortus Vaccine Sales Share by Application (2023-2028)
Table 42. Global Brucella Abortus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Brucella Abortus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Brucella Abortus Vaccine Revenue Share by Application (2017-2022)
Table 45. Global Brucella Abortus Vaccine Revenue Share by Application (2023-2028)
Table 46. Brucella Abortus Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 47. Global Brucella Abortus Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
Table 48. North America Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 49. North America Brucella Abortus Vaccine Sales by Type (2023-2028) & (K Units)
Table 50. North America Brucella Abortus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Brucella Abortus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. North America Brucella Abortus Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. North America Brucella Abortus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Brucella Abortus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Brucella Abortus Vaccine Sales by Country (2017-2022) & (K Units)
Table 57. North America Brucella Abortus Vaccine Sales by Country (2023-2028) & (K Units)
Table 58. North America Brucella Abortus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Brucella Abortus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 61. Europe Brucella Abortus Vaccine Sales by Type (2023-2028) & (K Units)
Table 62. Europe Brucella Abortus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Brucella Abortus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 65. Europe Brucella Abortus Vaccine Sales by Application (2023-2028) & (K Units)
Table 66. Europe Brucella Abortus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Brucella Abortus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Brucella Abortus Vaccine Sales by Country (2017-2022) & (K Units)
Table 69. Europe Brucella Abortus Vaccine Sales by Country (2023-2028) & (K Units)
Table 70. Europe Brucella Abortus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Brucella Abortus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Brucella Abortus Vaccine Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Brucella Abortus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Brucella Abortus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Brucella Abortus Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Brucella Abortus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Brucella Abortus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Brucella Abortus Vaccine Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Brucella Abortus Vaccine Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Brucella Abortus Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Brucella Abortus Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Brucella Abortus Vaccine Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Brucella Abortus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Brucella Abortus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Brucella Abortus Vaccine Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Brucella Abortus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Brucella Abortus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Brucella Abortus Vaccine Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Brucella Abortus Vaccine Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Brucella Abortus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Brucella Abortus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Brucella Abortus Vaccine Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Brucella Abortus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Brucella Abortus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Brucella Abortus Vaccine Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Brucella Abortus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Brucella Abortus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 108. Zoetis Corporation Information
Table 109. Zoetis Description and Major Businesses
Table 110. Zoetis Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 111. Zoetis Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Zoetis Recent Developments
Table 113. CEVA Corporation Information
Table 114. CEVA Description and Major Businesses
Table 115. CEVA Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 116. CEVA Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. CEVA Recent Developments
Table 118. Merck Animal Health Corporation Information
Table 119. Merck Animal Health Description and Major Businesses
Table 120. Merck Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 121. Merck Animal Health Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Merck Animal Health Recent Developments
Table 123. Biovet Corporation Information
Table 124. Biovet Description and Major Businesses
Table 125. Biovet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 126. Biovet Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Biovet Recent Developments
Table 128. CAVAC Corporation Information
Table 129. CAVAC Description and Major Businesses
Table 130. CAVAC Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 131. CAVAC Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. CAVAC Recent Developments
Table 133. JOVAC Corporation Information
Table 134. JOVAC Description and Major Businesses
Table 135. JOVAC Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 136. JOVAC Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. JOVAC Recent Developments
Table 138. Merial Corporation Information
Table 139. Merial Description and Major Businesses
Table 140. Merial Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 141. Merial Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Merial Recent Developments
Table 143. Colorado Serum Company Corporation Information
Table 144. Colorado Serum Company Description and Major Businesses
Table 145. Colorado Serum Company Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 146. Colorado Serum Company Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Colorado Serum Company Recent Developments
Table 148. VECOL Corporation Information
Table 149. VECOL Description and Major Businesses
Table 150. VECOL Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 151. VECOL Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. VECOL Recent Developments
Table 153. Tecnovax Corporation Information
Table 154. Tecnovax Description and Major Businesses
Table 155. Tecnovax Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 156. Tecnovax Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Tecnovax Recent Developments
Table 158. Indian Immunologicals Corporation Information
Table 159. Indian Immunologicals Description and Major Businesses
Table 160. Indian Immunologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 161. Indian Immunologicals Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Indian Immunologicals Recent Developments
Table 163. Vetal Corporation Information
Table 164. Vetal Description and Major Businesses
Table 165. Vetal Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 166. Vetal Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Vetal Recent Developments
Table 168. Dollvet Corporation Information
Table 169. Dollvet Description and Major Businesses
Table 170. Dollvet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 171. Dollvet Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Dollvet Recent Developments
Table 173. Centro Diagnostico Veterinario Corporation Information
Table 174. Centro Diagnostico Veterinario Description and Major Businesses
Table 175. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 176. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Centro Diagnostico Veterinario Recent Developments
Table 178. Onderstepoort Biological Products Corporation Information
Table 179. Onderstepoort Biological Products Description and Major Businesses
Table 180. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 181. Onderstepoort Biological Products Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Onderstepoort Biological Products Recent Developments
Table 183. Institute of Animal Health and Veterinary Biologicals Corporation Information
Table 184. Institute of Animal Health and Veterinary Biologicals Description and Major Businesses
Table 185. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 186. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Institute of Animal Health and Veterinary Biologicals Recent Developments
Table 188. Biogenesis Bago Corporation Information
Table 189. Biogenesis Bago Description and Major Businesses
Table 190. Biogenesis Bago Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 191. Biogenesis Bago Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Biogenesis Bago Recent Developments
Table 193. Instituto Rosenbusch Corporation Information
Table 194. Instituto Rosenbusch Description and Major Businesses
Table 195. Instituto Rosenbusch Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 196. Instituto Rosenbusch Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Instituto Rosenbusch Recent Developments
Table 198. SYVA Laboratorios Corporation Information
Table 199. SYVA Laboratorios Description and Major Businesses
Table 200. SYVA Laboratorios Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 201. SYVA Laboratorios Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. SYVA Laboratorios Recent Developments
Table 203. CZ Veterinaria Corporation Information
Table 204. CZ Veterinaria Description and Major Businesses
Table 205. CZ Veterinaria Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 206. CZ Veterinaria Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. CZ Veterinaria Recent Developments
Table 208. Hester Biosciences Corporation Information
Table 209. Hester Biosciences Description and Major Businesses
Table 210. Hester Biosciences Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 211. Hester Biosciences Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 212. Hester Biosciences Recent Developments
Table 213. Qilu Animal Health Corporation Information
Table 214. Qilu Animal Health Description and Major Businesses
Table 215. Qilu Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 216. Qilu Animal Health Brucella Abortus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 217. Qilu Animal Health Recent Developments
Table 218. Key Raw Materials Lists
Table 219. Raw Materials Key Suppliers Lists
Table 220. Brucella Abortus Vaccine Distributors List
Table 221. Brucella Abortus Vaccine Customers List
Table 222. Brucella Abortus Vaccine Market Trends
Table 223. Brucella Abortus Vaccine Market Drivers
Table 224. Brucella Abortus Vaccine Market Challenges
Table 225. Brucella Abortus Vaccine Market Restraints
Table 226. Research Programs/Design for This Report
Table 227. Key Data Information from Secondary Sources
Table 228. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucella Abortus Vaccine Product Picture
Figure 3. Global Brucella Abortus Vaccine Market Share by Type in 2021 & 2028
Figure 3. DNA Vaccines Product Picture
Figure 4. Subunit Vaccines Product Picture
Figure 5. Vector Vaccines Product Picture
Figure 6. B. Abortus Recombinant Mutants Product Picture
Figure 7. Others Product Picture
Figure 8. Global Brucella Abortus Vaccine Market Share by Application in 2021 & 2028
Figure 9. Cattles
Figure 10. Sheep
Figure 11. Pigs
Figure 12. Others
Figure 13. Brucella Abortus Vaccine Report Years Considered
Figure 14. Global Brucella Abortus Vaccine Sales 2017-2028 (K Units)
Figure 15. Global Brucella Abortus Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Brucella Abortus Vaccine Revenue 2017-2028 (US$ Million)
Figure 17. Global Brucella Abortus Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Brucella Abortus Vaccine Sales Market Share by Region (2017-2022)
Figure 19. Global Brucella Abortus Vaccine Sales Market Share by Region (2023-2028)
Figure 20. North America Brucella Abortus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 21. North America Brucella Abortus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Brucella Abortus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Brucella Abortus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Brucella Abortus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Brucella Abortus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Brucella Abortus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Brucella Abortus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Brucella Abortus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Brucella Abortus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Brucella Abortus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Brucella Abortus Vaccine in the World: Market Share by Brucella Abortus Vaccine Revenue in 2021
Figure 32. Global Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Brucella Abortus Vaccine Sales Market Share by Type (2017-2028)
Figure 34. Global Brucella Abortus Vaccine Revenue Market Share by Type (2017-2028)
Figure 35. Global Brucella Abortus Vaccine Sales Market Share by Application (2017-2028)
Figure 36. Global Brucella Abortus Vaccine Revenue Market Share by Application (2017-2028)
Figure 37. North America Brucella Abortus Vaccine Sales Market Share by Type (2017-2028)
Figure 38. North America Brucella Abortus Vaccine Revenue Market Share by Type (2017-2028)
Figure 39. North America Brucella Abortus Vaccine Sales Market Share by Application (2017-2028)
Figure 40. North America Brucella Abortus Vaccine Revenue Market Share by Application (2017-2028)
Figure 41. North America Brucella Abortus Vaccine Sales Share by Country (2017-2028)
Figure 42. North America Brucella Abortus Vaccine Revenue Share by Country (2017-2028)
Figure 43. U.S. Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Brucella Abortus Vaccine Sales Market Share by Type (2017-2028)
Figure 46. Europe Brucella Abortus Vaccine Revenue Market Share by Type (2017-2028)
Figure 47. Europe Brucella Abortus Vaccine Sales Market Share by Application (2017-2028)
Figure 48. Europe Brucella Abortus Vaccine Revenue Market Share by Application (2017-2028)
Figure 49. Europe Brucella Abortus Vaccine Sales Share by Country (2017-2028)
Figure 50. Europe Brucella Abortus Vaccine Revenue Share by Country (2017-2028)
Figure 51. Germany Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. France Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Brucella Abortus Vaccine Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Brucella Abortus Vaccine Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Brucella Abortus Vaccine Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Brucella Abortus Vaccine Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Brucella Abortus Vaccine Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Brucella Abortus Vaccine Revenue Share by Region (2017-2028)
Figure 62. China Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. India Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Brucella Abortus Vaccine Sales Market Share by Type (2017-2028)
Figure 73. Latin America Brucella Abortus Vaccine Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Brucella Abortus Vaccine Sales Market Share by Application (2017-2028)
Figure 75. Latin America Brucella Abortus Vaccine Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Brucella Abortus Vaccine Sales Share by Country (2017-2028)
Figure 77. Latin America Brucella Abortus Vaccine Revenue Share by Country (2017-2028)
Figure 78. Mexico Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Brucella Abortus Vaccine Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Brucella Abortus Vaccine Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Brucella Abortus Vaccine Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Brucella Abortus Vaccine Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Brucella Abortus Vaccine Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Brucella Abortus Vaccine Revenue Share by Country (2017-2028)
Figure 87. Turkey Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Brucella Abortus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 90. Brucella Abortus Vaccine Value Chain
Figure 91. Brucella Abortus Vaccine Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
